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Background
Cardiac involvement drives outcome in systemic AL
amyloidosis. Late gadolinium enhancement (LGE) CMR
is useful for the detection of cardiac amyloid, but
characteristic LGE patterns do not always occur or may
appear late in the disease. Using CMR T1 mapping, we
measured the pre contrast myocardial T1 and myocar-
dial Extracellular Volume (ECV), reflecting myocardial
amyloidosis burden and determined their prognostic
significance.
Methods
102 patients underwent CMR and T1 mapping pre- and
post contrast. Myocardial ECV was calculated at contrast
equilibrium. 54 healthy volunteers served as controls.
Patients were followed up for a median duration of 23
months and survival analyses were performed. A second-
ary analysis compared predictive power of the following
techniques: pre contrast T1, post contrast T1, ECV at
equilibrium (ECVi) and ECV at 15 minutes i.e. bolus only
ECV (ECVb).
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Figure 1 Kaplan Meier survival curves after median duration of follow up of 23 months for: (A) ECVi; (B) ECVb; (C) pre-contrast
myocardial T1.
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Results
ECVi and ECVb were both raised compared to normals
(both ECVi and ECVb means: 0.44 ± 0.12 vs 0.25 ± 0.02
for healthy volunteers, P < 0.001), as was native T1
(1081 ms vs 954 ms, P < 0.001). All 3 tracked pre-test
probability of cardiac involvement, cardiac biomarkers
and systolic and diastolic dysfunction. During follow-up,
25 deaths occurred. An ECVi of > 0.44 carried a hazard
ratio for death of 3.76 (95% CI: 1.50 - 9.43), P = 0.005
and pre contrast T1 of > 1080 ms = HR 3.38 (95% CI:
1.21 - 9.45), p = 0.020. ECVi and ECVb performed
similarly. Both ECVi and ECVb were stronger predictors
of survival than pre contrast T1 as assessed by the
(Harrell’s C statistic). Isolated post contrast T1 was non
predictive.
Conclusions
Myocardial ECV (bolus or infusion technique) and pre
contrast T1 in AL amyloidosis are strong predictors of
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